PC_010 Sensitivity and Specificity of a complete real-time PCR genotyping, identifying 19 high-risk (HR) and 9 low-risk (LR) HPV types for CIN2+ Detection
L.F. Fleider, M.D.L.A. Tinnirello, L.G. Gallo Vaulet, A.T. Toledano, A.P. Puñal, C.A. Alonso, J.G. Giarmana, S.L. La Valle, M.R.F. Rodriguez Fermepin, J. Ortiz
Hospital De Clinicas Jose De San Martin, Ciudad De Buenos Aires-Nuñez, Argentine
PC_014 Histological Yield of HR-HPV Positive, Cytology-Negative Referrals to Colposcopy in a Model 3 Hospital in Ireland
S.R. Nazir Nazir (1), S. Jaleel (1), H. Elves (2), E. Mccole (2), K. Khan (1), M. Collins (2), M. Gardasanic (1)
(1) Department Of Obstetrics And Gynaecology And Colposcopy, Letterkenny University Hospital, Letterkenny, Irlande, (2) Department Of Colposcopy, Letterkenny University Hospital, Letterkenny, Irlande
PC_015 Sustaining and scaling HPV-based cervical screening in hospital-based antenatal care: an implementation evaluation
J. Dixon (1), A. Machado Colling (1), C. Nightingale (1), D. Rolnik (2), D. Hawkes (3), M. Saville (3), A. Bastable (4), M. Smith (5), J. Brotherton (1)
(1) The University Of Melbourne, Melbourne, Australie, (2) Monash University, Melbourne, Australie, (3) The Australian Centre For The Prevention Of Cervical Cancer, Melbourne, Australie, (4) Cancer Council Victoria, Melbourne, Australie, (5) The University Of Sydney, Sydney, Australie
PC_016 Determining the genetic risk for cervical cancer
A. Minaeva (1), M. Vinokurov (2), G. Leshkina (2), K. Mironov (2), A. Efimova (1)
(1) Medical Institute, Peoples’ Friendship University Of Russia Named After Patrice Lumumba (rudn University); Fomin Clinic, Moscow, Russie (Fédération de), (2) Central Research Institute For Epidemiology, Federal Service For Surveillance On Consumer Rights Protection And Human Wellbeing, Moscow, Russia, Moscow, Russie (Fédération de)
PC_017 Determinants of Non-Participation in Cervical Cancer Screening by Human Papilloma Virus Self-Sampling among Urban Women in Mumbai, India.
S. Pimple (1), D. Thiruvengadam (2), G. Mishra (3), A. Maheshwari (4), S. Biswas (4), K. Prasad (5)
(1) Head Of The Department Of Preventive Oncology, Tmh, Mumbai, Mumbai, Inde, (2) Fellow 2, Preventive Oncology, Tmh, Mumbai, Mumbai, Inde, (3) Professor, Department Of Preventive Oncology, Tata Memorial Hospital, Mumbai, Mumbai, Inde, (4) Head Of Department Of Gynec-Oncology Tmh, Mumbai, Mumbai, Inde, (5) Director, Manipal School Of Information Sciences, Mahe, Manipal, Inde
PC_019 Psychological Parameters in Individuals with a Positive HPV Test and Normal Cytology (Pap I or IIa) Compared to Individuals with a Negative or Unknown HPV Status (HAPPI study)
W. Reents (1), A. Hildebrandt (1), M. Schild-Suhren (2), A. Lindig (1)
(1) Department Of Psychology, Faculty Of Medicine And Health Sciences, University Medicine Oldenburg, Carl Von Ossietzky Universität Oldenburg, Oldenburg, Allemagne, (2) Cervical Dysplasia Unit, Department Of Gynecology, Faculty Of Medicine And Health Sciences, University Medicine Oldenburg, Klinikum Oldenburg, Oldenburg, Allemagne
PC_020 Multiple Dimensions of Social Vulnerability and Cervical Cancer Screening Uptake: A cohort Study
J. Haury (1), S. Crequit (2), G. Canlorbe (1), B. Renevier (2)
(1) Pitié Salpêtrière, Paris, France, (2) Hôpital Andre Gregoire, Montreuil, France
PC_021 Co-designing the ideal cervical screening program with and for people with disability
M. Galrao, F. Townsend, N. Hofler
Sexual Health Quarters, Perth, Australie
PC_023 Accuracy of HPV DNA Methylation tests in the Triage of High-Risk HPV–Positive Women
K. Pcolkina (1), O. Plisko (2), I. Jermakova (1), D. Araja (1), D. Kunicina (1), A. Cerneikina (3), Z. Daneberga (3), J. Zodzika (4)
(1) Riga East Clinical University Hospital, Riga, Lettonie, (2) Riga East Clinical University Hospital, Riga Stradiņš Univeristy, Riga, Lettonie, (3) Riga Stradiņš University, Institute Of Oncology And Molecular Genetics, Riga, Lettonie, (4) Riga East Clinical University Hospital, Riga Stradiņš University, Riga, Lettonie
PC_024 HPV Viral Load: A Potential Biomarker for Diagnosis and Clinical Monitoring
F.D. Chiarot, V.R. Silva, J.L. Cunha, L.Z. Renaldi
Ipog, Sao Paulo, Brésil
